Tage Honore serves as Executive at Vanda Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Tage Honore has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 17, 2024 involved receiving (via award) 20,529 shares valued at $0.
Tage Honore currently holds 64,244 shares of Vanda Pharmaceuticals Inc. (VNDA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tage Honore has been a net neutral trader of VNDA stock. They have purchased $0 and sold $0 worth of shares.
Tage Honore's most recent insider trade was on May 17, 2024, when they sold 20,529 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 15, 2023 | VNDA | $0 | Award | 26,408 | $N/A | Discretionary |